|
Tocris
sb334867 ![]() Sb334867, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/sb334867/product/Tocris Average 95 stars, based on 1 article reviews
sb334867 - by Bioz Stars,
2026-05
95/100 stars
|
Buy from Supplier |
|
Tocris
ox1r antagonist ![]() Ox1r Antagonist, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/ox1r antagonist/product/Tocris Average 95 stars, based on 1 article reviews
ox1r antagonist - by Bioz Stars,
2026-05
95/100 stars
|
Buy from Supplier |
|
Tocris
mem medium ![]() Mem Medium, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mem medium/product/Tocris Average 95 stars, based on 1 article reviews
mem medium - by Bioz Stars,
2026-05
95/100 stars
|
Buy from Supplier |
|
Glaxo Smith
sb 334867 a ![]() Sb 334867 A, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/sb 334867 a/product/Glaxo Smith Average 86 stars, based on 1 article reviews
sb 334867 a - by Bioz Stars,
2026-05
86/100 stars
|
Buy from Supplier |
|
Tocris
sb 334867 ![]() Sb 334867, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/sb 334867/product/Tocris Average 95 stars, based on 1 article reviews
sb 334867 - by Bioz Stars,
2026-05
95/100 stars
|
Buy from Supplier |
|
Tocris
orx1r antagonist sb 334867 ![]() Orx1r Antagonist Sb 334867, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/orx1r antagonist sb 334867/product/Tocris Average 95 stars, based on 1 article reviews
orx1r antagonist sb 334867 - by Bioz Stars,
2026-05
95/100 stars
|
Buy from Supplier |
Journal: Journal of Cellular Biochemistry
Article Title: Orexin‐A Inhibits Lipopolysaccharide‐Induced Cell Migration in Cultured Mouse Astrocytes via Activation of Orexin 1 Receptor: Involvement of GABA Signaling
doi: 10.1002/jcb.70089
Figure Lengend Snippet: Effect of the treatment of OXA (10 nM) with or without the OX1RA, SB334867 (100 nM) pretreatment on LPS (100 ng/mL)‐induced changes in astrocyte migration. (a) Cell migration assay was performed and the migration images were captured at 0 and 48 h after the start of LPS treatment. (b) A graph representing the percentage of the migrated area, with 0 h set as 0%. The LPS‐induced increase in astrocyte migration was reduced by OXA treatment, and this reduction was restored by pretreatment of OX1RA. Scale bar = 200 μm. Data are expressed as mean ± SEM. n = 7. ** p < 0.01 versus control; ## p < 0.01 and ### p < 0.001 versus LPS + OXA.
Article Snippet: The cells were then pretreated with or without LPS (100 ng/mL) in MEM medium for 30 min, followed by treatment with the OX1R antagonist (OX1RA),
Techniques: Migration, Cell Migration Assay, Control
Journal: Journal of Cellular Biochemistry
Article Title: Orexin‐A Inhibits Lipopolysaccharide‐Induced Cell Migration in Cultured Mouse Astrocytes via Activation of Orexin 1 Receptor: Involvement of GABA Signaling
doi: 10.1002/jcb.70089
Figure Lengend Snippet: Effect of the treatment of OXA (10 nM) with or without the OX1RA, SB334867 (100 nM) pretreatment on LPS (100 ng/mL)‐induced changes in KCC2 phosphorylation in primary cultured astrocytes. (a and b) Representative Western blots (a) and a graph (b) showed that the LPS‐induced increase in the ratio of phosphorylation (p‐KCC2) at residue Thr‐1007 to total protein expression of KCC2 was reduced by OXA treatment, and this reduction was restored by pretreatment of OX1RA. Data are expressed as mean ± SEM. n = 8. * p < 0.05 versus control; # p < 0.05 versus LPS + OXA.
Article Snippet: The cells were then pretreated with or without LPS (100 ng/mL) in MEM medium for 30 min, followed by treatment with the OX1R antagonist (OX1RA),
Techniques: Phospho-proteomics, Cell Culture, Western Blot, Residue, Expressing, Control
Journal: Journal of Cellular Biochemistry
Article Title: Orexin‐A Inhibits Lipopolysaccharide‐Induced Cell Migration in Cultured Mouse Astrocytes via Activation of Orexin 1 Receptor: Involvement of GABA Signaling
doi: 10.1002/jcb.70089
Figure Lengend Snippet: Effect of the treatment of OXA (10 nM) with or without the OX1RA, SB334867 (100 nM) pretreatment on LPS (100 ng/mL)‐induced changes in GABA‐immunoreactivity in primary cultured astrocytes. (a and b) Representative images (a) and a graph (b) show that LPS treatment increased GABA immunoreactivity (red) in cultured astrocytes, and OXA treatment further enhanced this increase. This effect was inhibited by pretreatment of OX1RA. Scale bar = 50 μm. Data are expressed as mean ± SEM. n = 3. ** p < 0.01, *** p < 0.0001 versus Control; # p < 0.05, ## p < 0.01 versus LPS + OXA.
Article Snippet: The cells were then pretreated with or without LPS (100 ng/mL) in MEM medium for 30 min, followed by treatment with the OX1R antagonist (OX1RA),
Techniques: Cell Culture, Control
Journal: Journal of Cellular Biochemistry
Article Title: Orexin‐A Inhibits Lipopolysaccharide‐Induced Cell Migration in Cultured Mouse Astrocytes via Activation of Orexin 1 Receptor: Involvement of GABA Signaling
doi: 10.1002/jcb.70089
Figure Lengend Snippet: Effect of the treatment of OXA (10 nM) with or without the OX1RA, SB334867 (100 nM) pretreatment on LPS (100 ng/mL)‐induced changes in the expression of GAT1 and GAT3 in primary cultured astrocytes. (a–d) Immunocytochemistry (a and b; red) and Western blot analysis (c and d) using antibodies against GAT1 show that LPS treatment reduced GAT1 expression in astrocytes. OXA treatment prevented the LPS‐induced decrease in GAT1 expression, and this effect was blocked by pretreatment of OX1RA. (e–h) Immunocytochemistry (e and f; red) and Western blot analysis (g and h) using antibodies against GAT3 show that LPS treatment reduced GAT3 expression in astrocytes. OXA treatment prevented the LPS‐induced decrease in GAT3 expression, and this effect was also blocked by pretreatment of OX1RA. Scale bar = 50 μm. Data are expressed as mean ± SEM. n = 3‐4. *** p < 0.0001 versus Control; ### p < 0.001 versus LPS + OXA.
Article Snippet: The cells were then pretreated with or without LPS (100 ng/mL) in MEM medium for 30 min, followed by treatment with the OX1R antagonist (OX1RA),
Techniques: Expressing, Cell Culture, Immunocytochemistry, Western Blot, Control
Journal: Journal of Cellular Biochemistry
Article Title: Orexin‐A Inhibits Lipopolysaccharide‐Induced Cell Migration in Cultured Mouse Astrocytes via Activation of Orexin 1 Receptor: Involvement of GABA Signaling
doi: 10.1002/jcb.70089
Figure Lengend Snippet: Effect of the treatment of OXA (10 nM) with or without the OX1RA, SB334867 (100 nM) pretreatment on LPS (100 ng/mL)‐induced changes in ERK and p38 MAPK phosphorylation in primary cultured astrocytes. (a and b) Representative western blots and graphs showed that the LPS‐induced increases in the ratio of phosphorylation to total protein expression of ERK (a) and p38 MAPK (b) were reduced by OXA treatment, and this reduction was blocked by pretreatment of OX1RA. Data are expressed as mean ± SEM. n = 4–5. * p < 0.05, ** p < 0.01, *** p < 0.001 versus control; # p < 0.05 versus LPS + OXA.
Article Snippet: The cells were then pretreated with or without LPS (100 ng/mL) in MEM medium for 30 min, followed by treatment with the OX1R antagonist (OX1RA),
Techniques: Phospho-proteomics, Cell Culture, Western Blot, Expressing, Control